Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Medroxyprogesterone Acetate: From Signal to Strategy
2026-10-09
A source-grounded perspective on how Medroxyprogesterone acetate can support receptor-aware translational research while avoiding overinterpretation of findings from endometrial, renal, and neurobiological models.
-
GPNMB Model Predicts Immunotherapy Response in ESCC
2026-10-09
The reference study presents a multimodal framework that combines circulating soluble GPNMB, CAF-Epi niche features, and clinicopathological variables to predict response to PD-1 blockade in esophageal squamous cell carcinoma. Its main contribution is to connect a measurable plasma biomarker with tumor–immune biology, while its clinical applicability remains dependent on independent validation, assay standardization, and fuller reporting of model performance.
-
Tankyrase Inhibition and Hippo Signaling in HCC
2026-10-08
Jia et al. reported that the tankyrase inhibitors XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity and increasing AMOTL1/2 protein levels. The study’s main innovation is its emphasis on Hippo-pathway regulation as a mechanism linking tankyrase inhibition to HCC growth control, while also highlighting pathway crosstalk with MEK and AKT signaling.
-
Genotyping Kit for Target Alleles: Evidence
2026-10-07
The Genotyping Kit for target alleles is a vendor-described direct-template system for PCR amplification of genomic DNA from insects, tissues, fishes, and cells. Its value is workflow simplification, while allele specificity, analytical validity, and biological interpretation still depend on the assay and study design.
-
DHEA as a Translational Probe in Brain and Ovary
2026-10-07
Dehydroepiandrosterone (DHEA) is best viewed as a context-dependent research probe linking steroid signaling, neuroprotection, apoptosis inhibition, and inflammatory ovarian biology. This article interprets the evidence, defines translational boundaries, and outlines a non-operational framework for more rigorous model selection.
-
Mianserin–Cyclodextrin Complexation and Toxicity
2026-10-06
A 2021 study examined how heptakis (2,6-di-O-methyl)-β-cyclodextrin interacts with mianserin hydrochloride and whether complex formation changes cellular toxicity. Its orthogonal evidence indicates that complexation occurs, but unlike the previously discussed β-cyclodextrin system, the methylated cyclodextrin did not protect cells from mianserin-associated viability loss.
-
Ferroptosis Signature and Atorvastatin in HCC
2026-10-06
A 2025 study integrated ferroptosis-related transcriptomics, survival modeling, Connectivity Map screening, and preclinical validation to develop a four-gene prognostic signature for hepatocellular carcinoma (HCC) and identify Atorvastatin as a candidate agent. The findings support further investigation of ferroptosis biology in HCC, but they remain preclinical and do not establish clinical anticancer efficacy.
-
4-Hydroxytamoxifen Product Overview
2026-10-05
4-Hydroxytamoxifen (SKU B6167) is described by APExBIO as an estrogen receptor modulator for conceptual research in endocrine-responsive models. No matched paper evidence was provided, so efficacy, mechanism, and application-specific performance are not established here.
-
RQ3025 Vaccine Evidence and Immunoassay Context
2026-10-05
A source-grounded overview of the preclinical evidence for RQ3025, a broad-spectrum bivalent mRNA vaccine candidate, and the interpretive role of human-IgG immunodetection reagents. The discussion separates reported animal findings from broader translational interpretation and explains why a fluorescent secondary antibody cannot, by itself, establish neutralization or clinical protection.
-
Sex Differences in Angiotensin II Hypertension
2026-10-04
Xue, Pamidimukkala, and Hay showed that chronic angiotensin II produced a substantially larger blood-pressure increase in conscious male mice than in females, while gonadectomy altered the response in opposite directions. By combining telemetry, baroreflex assessment, and ganglionic blockade, the study connected sex-dependent hypertension with differences in autonomic and reflex cardiovascular regulation.
-
PINK1/Park2 Mitophagy in NAFLD
2026-10-03
A 2024 study examined whether Park2-associated mitophagy is linked to lipid accumulation, inflammation, and mitochondrial injury in a cellular NAFLD model. Its findings support a protective association, while the model design and mitophagy readouts limit direct translation to patients or therapeutic practice.
-
KU-60019: Reframing ATM Inhibition for Translation
2026-10-01
A mechanistic and translational perspective on KU-60019 as an ATM kinase inhibitor, connecting DNA damage response inhibition, glioma radiosensitization, repair biology, and experimental strategy.
-
SkQ1 and Mitochondrial Signalling in Ovarian Cancer
2026-10-01
The reference study used a time-resolved orthotopic ovarian cancer model to test whether mitochondrial hydrogen peroxide, apoptotic caspases, or necroptotic signalling drives skeletal muscle atrophy. SkQ1 reduced late-stage mitochondrial H2O2 emission and caspase activity but did not preserve type IIB muscle fibre size, challenging a simple causal model of mitochondrial oxidative stress in cancer-associated muscle loss.
-
DHEA in PCOS: From Model to Mechanism
2026-09-30
DHEA is more than an ovarian steroidogenic trigger: it is a mechanistic research variable that can expose mitochondrial cholesterol transport and SIRT1-dependent regulation in PCOS models. This guide translates the latest DHEA-based PCOS findings into assay design, interpretation, and cross-system experimental decisions.
-
Fenipentol in Reproducible Cell Assays
2026-09-30
Learn how Fenipentol (SKU C8318) can be evaluated in cell viability, proliferation, cytotoxicity, and secretion-related workflows without overinterpreting computational or animal evidence. This scenario-based guide covers solvent controls, concentration-response design, data interpretation, and practical product-selection criteria.